Patent US4424207A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4424207A Expired / Lapsed US ⏱️ 0.0 years remaining

Enzyme inhibitors

Assignee: Ferring Pharmaceuticals Ltd
•
Filing: 1981-08-05
•
Granted: 1984-01-03
•
Expires: 2001-08-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Preparation of renin inhibitors based on the structure of natural renin substrate at residues 6 to 13 from the amino terminal thereof, the inhibitors being polypeptide analogues having in particular an isosteric non-peptide link corresponding to the 10, 11 peptide link of the substrate, and preparation of dipeptide analogues.

Inventors

  • 👤 Michael Szelke
  • 👤 David M. Jones
  • 👤 Allan Hallett

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 21:54
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/02; C07K5/0227; C07K5/04; C07K5/10; C07K5/1024; C07K7/00; C07K7/04; C07K7/14; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/86

Claims Analysis

Total Claims: 42
Claim 1
Independent Claim 344 words
A polypeptide analogue of the formula: ##STR38## where: Pro, Phe and His may be in substituted form; X=H, a lower aliphatic acyl (C 1 =C 5 ), t-butyloxycarbonyl, an aromatic acyl or an L- or D- amino- acyl residue, which may itself be N-protected similarly; Y=D- or L-His or other D- or L- basic or aromatic aminoacyl residue, or is absent; ##STR39## where the configuration at asymmetric centres * is either R or S, where in VIII the hydroxy group may be present as such or protected in either --OR 4 or ester ##STR40## form where R 4 is as given under W below and where R 1 and R 2 , the same or different= i Pro (isopropyl), i Bu (isobutyl), Bzl (benzyl) or other lipophilic or aromatic amino-acid side chain; R 3 =--H; lower alkyl (C 1 -C 5 ); or --SO 2 Ph, --SO 2 C 6 H 4 CH 3 (p), Boc, formyl or other N-protecting group; B=D- or L- Val or Ile or other D- or L- lipophilic aminoacyl residue; Z=D- or L- Tyr, Phe, His or other L- or D-aromatic amino-acyl residue; and W= (a) OH (b) --OR 4 where R 4 =(i) lower alkyl C 1 -C 5 (ii) cycloalkyl C 3 -C 7 or Bzl (c) --NH 2 (d) --NHR 5 or --N(R 5 ) 2 wherein R 5 is an N-protecting group or R 4 (e) L- or D-Lys (f) L- or D-Arg unprotected or as the ester or amide (g) L- or D-Ser and (h) amino alcohol derived from (e)-(g) unprotected protected as such or in ester or ether form; Z+W=alcohol derived from (i) L-Tyr (ii) L-Phe (iii) D-Tyr or D-Phe (iv) His such polypeptide being in the above form or modified by isosteric replacement of one or more remaining peptide bonds by reduced, --CH 2 --NH--, keto, ##STR41##hydroxy, --CH(OH)--CH 2 --, or hydrocarbon, --CH 2 --CH 2 -- isosteric links and further being in free form or in protected form at one or more remaining peptide, carboxyl, amino, hydroxy or other reactive groups.
Claim 2
Dependent Claim 344 words
A polypeptide analogue of the formula: ##STR38## where: Pro, Phe and His may be in substituted form; X=H, a lower aliphatic acyl (C 1 =C 5 ), t-butyloxycarbonyl, an aromatic acyl or an L- or D- amino- acyl residue, which may itself be N-protected similarly; Y=D- or L-His or other D- or L- basic or aromatic aminoacyl residue, or is absent; ##STR39## where the configuration at asymmetric centres * is either R or S, where in VIII the hydroxy group may be present as such or protected in either --OR 4 or ester ##STR40## form where R 4 is as given under W below and where R 1 and R 2 , the same or different= i Pro (isopropyl), i Bu (isobutyl), Bzl (benzyl) or other lipophilic or aromatic amino-acid side chain; R 3 =--H; lower alkyl (C 1 -C 5 ); or --SO 2 Ph, --SO 2 C 6 H 4 CH 3 (p), Boc, formyl or other N-protecting group; B=D- or L- Val or Ile or other D- or L- lipophilic aminoacyl residue; Z=D- or L- Tyr, Phe, His or other L- or D-aromatic amino-acyl residue; and W= (a) OH (b) --OR 4 where R 4 =(i) lower alkyl C 1 -C 5 (ii) cycloalkyl C 3 -C 7 or Bzl (c) --NH 2 (d) --NHR 5 or --N(R 5 ) 2 wherein R 5 is an N-protecting group or R 4 (e) L- or D-Lys (f) L- or D-Arg unprotected or as the ester or amide (g) L- or D-Ser and (h) amino alcohol derived from (e)-(g) unprotected protected as such or in ester or ether form; Z+W=alcohol derived from (i) L-Tyr (ii) L-Phe (iii) D-Tyr or D-Phe (iv) His such polypeptide being in the above form or modified by isosteric replacement of one or more remaining peptide bonds by reduced, --CH 2 --NH--, keto, ##STR41##hydroxy, --CH(OH)--CH 2 --, or hydrocarbon, --CH 2 --CH 2 -- isosteric links and further being in free form or in protected form at one or more remaining peptide, carboxyl, amino, hydroxy or other reactive groups.
Claim 3
Dependent Claim 177 words
A polypeptide analogue, according to claim 1, of the formula: ##STR42## where X, Y, Pro, Phe and His are as in claim 1 A is as in claim 1 except that R 1 and R 2 , the same or difference= i Bu (isobutyl) or Bzl (benzyl) or other lipophilic or aromatic amino-acid side chain; R 3 =--H; or --SO 2 Ph, --SO 2 C 6 H 4 CH 3 (p), Boc, formyl or other N-protecting group; Z=Tyr, Phe or his other; W= (a) --OH (b) --OR 4 where R 4 =(i) lower alkyl C 1 -C 5 (ii) cycloalkyl C 3 -C 7 or Bzl (c) --NH 2 (d) --NHR 5 or --N(R 5 ) 2 wherein R 5 is an N-protecting group or R 4 (f) L- or D-Lys (g) L- or D-Arg unprotected or as the ester or amide (h) L- or D-Ser and (j) amino alcohol derived from (f)-(h) unprotected or protected as such or in ester or ether form; Z+W=alcohol derived from (i) L-Tyr (ii) L-Phe (iii) D-Tyr or D-Phe (iv) His.
Claim 4
Dependent Claim 115 words
A polypeptide analogue, according to claim 1, of the formula: ##STR43## where X, Y, Pro, Phe and His are as in claim 1 A is as in claim 1 except that R 1 = i Bu (isobutyl) or Bzl (benzyl) or other lipophilic or aromatic amino-acid side chain R 2 = i Pr (isopropyl), and R 3 =--H; or --SO 2 Ph, --SO 2 C 6 H 4 CH 3 (p), Boc, formyl or other N-protecting group Z is as in claim 1 W is as in claim 2 or Z+W=an alcohol derived from the aromatic residues specified for Z in claim 1, as such or protected in ester or ether form as specified therein.
Claim 5
Dependent Claim 24 words
A polypeptide according to claim 1, modified by isosteric replacement, as set out therein, at one or both of the Pro-Phe or Phe-His links.
Claim 6
Dependent Claim 21 words
A polypeptide according to claim 1 wherein the isosteric replacement at at least the 10,11 position is of the "reduced" kind.
Claim 7
Dependent Claim 21 words
A polypeptide according to claim 1 wherein the isosteric replacement at at least the 10,11 position is of the "hydroxy" kind.
Claim 8
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-reduced-Leu-Val-Tyr-OH.
Claim 9
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-reduced-Leu-Val-Tyr-OH.
Claim 10
Dependent Claim 3 words
The compound: H-Pro-Phe-His-Leu-reduced-Leu-Val-Tyr-OH.
Claim 11
Dependent Claim 3 words
The compound: H-Pro-Phe-His-Leu-reduced-Leu-Val-Tyr-OH.
Claim 12
Dependent Claim 6 words
The compound: H-His-Pro-Phe-His-Leu-reduced (SO 2 Ph)-Leu-Val-Tyr-OH.
Claim 13
Dependent Claim 6 words
The compound: H-His-Pro-Phe-His-Leu-reduced (SO 2 Ph)-Leu-Val-Tyr-OH.
Claim 14
Dependent Claim 3 words
The compound: H-DHis-Pro-Phe-His-Leu-reduced-Leu-Val-Tyr-OH.
Claim 15
Dependent Claim 3 words
The compound: H-DHis-Pro-Phe-His-Leu-reduced-Leu-Val-Tyr-OH.
Claim 16
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-reduced-Val-Ile-His-OH.
Claim 17
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-reduced-Val-Ile-His-OH.
Claim 18
Dependent Claim 3 words
The compound: H-DHis-Pro-Phe-His-Phe-reduced-Phe-Val-Tyr-OH.
Claim 19
Dependent Claim 3 words
The compound: H-DHis-Pro-Phe-His-Phe-reduced-Phe-Val-Tyr-OH.
Claim 20
Dependent Claim 3 words
The compound: H-DHis-Pro-Phe-His-Leu-reduced-Phe-Val-Tyr-OH.
Claim 21
Dependent Claim 3 words
The compound: H-DHis-Pro-Phe-His-Leu-reduced-Phe-Val-Tyr-OH.
Claim 22
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Phe-reduced-Phe-Val-Tyr-OH.
Claim 23
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Phe-reduced-Phe-Val-Tyr-OH.
Claim 24
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-reduced-Phe-Val-Tyr-OH.
Claim 25
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-reduced-Phe-Val-Tyr-OH.
Claim 26
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-reduced-Val-Ile-Tyr-OH.
Claim 27
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-reduced-Val-Ile-Tyr-OH.
Claim 28
Dependent Claim 3 words
The compound: H-Pro-His-Pro-Phe-His-Phe-reduced-Phe-Val-Tyr-Lys-OH.
Claim 29
Dependent Claim 3 words
The compound: H-Pro-His-Pro-Phe-His-Phe-reduced-Phe-Val-Tyr-Lys-OH.
Claim 30
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-reduced-Val-Val-Tyr-OH.
Claim 31
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-reduced-Val-Val-Tyr-OH.
Claim 32
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-hydroxy-Leu-Val-Tyr-OH.
Claim 33
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-hydroxy-Leu-Val-Tyr-OH.
Claim 34
Dependent Claim 3 words
The compound: H-Pro-Phe-His-Leu-hydroxy-Leu-Val-Tyr-OH.
Claim 35
Dependent Claim 3 words
The compound: H-Pro-Phe-His-Leu-hydroxy-Leu-Val-Tyr-OH.
Claim 36
Dependent Claim 3 words
The compound: H-DHis-Pro-Phe-His-Leu-hydroxy-Leu-Val-Tyr-OH.
Claim 37
Dependent Claim 3 words
The compound: H-DHis-Pro-Phe-His-Leu-hydroxy-Leu-Val-Tyr-OH.
Claim 38
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-hydroxy-Val-Ile-His-OH.
Claim 39
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-hydroxy-Val-Ile-His-OH.
Claim 40
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-keto-Val-Ile-His-OH.
Claim 41
Dependent Claim 3 words
The compound: H-His-Pro-Phe-His-Leu-keto-Val-Ile-His-OH.
Claim 42
Dependent Claim 24 words
A pharmaceutical composition comprising the polypeptide analogue of claim 1 with a pharmaceutically acceptable diluent, said polypeptide analogue being present in a renin-inhibiting amount.

References Cited (Backward Citations)

US4242256A Cited
US4198398A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-01-02 1987-07-04 1988-01-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-01-02 1991-07-04 1992-01-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-01-02 1995-07-04 1996-01-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag